Rinvoq (upadacitinib) is a JAK inhibitor approved by the FDA for multiple inflammatory conditions, including rheumatoid arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, psoriatic arthritis, and ankylosing spondylitis. The retail price exceeds $6,000 per month, placing it out of reach for many patients. The Rinvoq Patient Assistance program, operated by AbbVie through myAbbVie Assist, provides the drug free of charge to patients who meet financial and coverage criteria.
What the Rinvoq Patient Assistance Program Covers
The Rinvoq Patient Assistance program provides Rinvoq tablets (15 mg, 30 mg, and 45 mg strengths) at no cost to qualifying patients. The program covers all FDA-approved indications for Rinvoq, so whether you are prescribed the medication for rheumatoid arthritis, atopic dermatitis, or another approved condition, you can apply through the same pathway.
Approved patients receive a 30-day supply delivered to their home or prescriber’s office each month. The medication is shipped in standard packaging appropriate for oral tablets. Enrollment lasts for one year, with annual renewal required. The program also connects patients with a dedicated support team that assists with insurance navigation, prior authorization support, and general questions about Rinvoq therapy.
Eligibility Criteria
To qualify for Rinvoq Patient Assistance, you must meet the following conditions. You must be a U.S. citizen or legal resident with a valid prescription for Rinvoq from a licensed healthcare provider. You must lack insurance coverage that pays for Rinvoq, meaning you do not have Medicare Part D, Medicaid, VA benefits, Tricare, or commercial insurance that covers the medication.
Your household income must fall at or below a specified percentage of the Federal Poverty Level. AbbVie generally sets this threshold at 400% to 600% FPL for its specialty products. For 2026, 400% FPL is approximately $62,400 for an individual, and 600% FPL is approximately $93,600. Patients with incomes slightly above the cutoff who face documented financial hardship may be considered on a case-by-case basis.
Step-by-Step Application Process
The application requires your healthcare provider’s participation. Your prescriber downloads the myAbbVie Assist enrollment form from the Rinvoq Complete website or calls 1-800-222-6885 to request a copy. The prescriber section of the form captures your diagnosis, prescribed dosage, and the medical necessity of Rinvoq over alternative treatments.
You complete the patient section, which asks for your household income, insurance status, and contact information. Attach proof of income, such as your most recent federal tax return (Form 1040), two recent pay stubs, or a Social Security benefits statement. Include a copy of a government-issued photo ID. Your prescriber submits the complete package by fax or mail.
Processing takes 2 to 4 weeks. Once approved, your first shipment arrives within 5 to 10 business days. If you need Rinvoq before the application is processed, ask your prescriber about bridge samples or contact Rinvoq Complete for expedited review options.
Rinvoq Savings for Insured Patients
If you have commercial insurance that covers Rinvoq but your out-of-pocket cost is high, the Rinvoq Complete Savings Card can reduce your copay to as little as $5 per month. The savings card has an annual maximum benefit that varies by program year, typically between $16,000 and $20,000. This card is available only to patients with private or employer-sponsored insurance.
Patients with government insurance (Medicare Part D, Medicaid, Tricare, VA) cannot use manufacturer copay cards. Medicare beneficiaries should explore Medicare Extra Help for Part D cost reduction. Nonprofit copay assistance foundations, such as the Patient Access Network Foundation and the HealthWell Foundation, may also provide grants for Medicare patients taking JAK inhibitors.
Rinvoq and the AbbVie Patient Assistance Ecosystem
The Rinvoq PAP is part of the broader AbbVie Patient Assistance program (myAbbVie Assist). If you take other AbbVie medications, such as Humira, Skyrizi, or Venclexta, you can apply for assistance for multiple drugs through a single process. This streamlines paperwork and ensures consistent support across your treatment regimen.
AbbVie’s patient support infrastructure also includes a nurse ambassador program that provides one-on-one guidance for patients starting Rinvoq. Nurse ambassadors can answer questions about injection-free oral dosing, potential side effects, and coordinating Rinvoq with other treatments. This support is available to all Rinvoq patients regardless of how they pay for the medication.
Understanding Rinvoq’s Role in Treatment
Rinvoq is typically prescribed after patients have tried and failed conventional therapies such as methotrexate or biologic DMARDs. As an oral JAK inhibitor, it offers convenience over injectable biologics while delivering strong clinical efficacy. Phase 3 trials published in the New England Journal of Medicine showed significant improvements in ACR response rates for rheumatoid arthritis and EASI scores for atopic dermatitis compared to placebo and active comparators.
The FDA has issued boxed warnings for JAK inhibitors, including Rinvoq, regarding risks of serious infections, malignancy, thrombosis, and cardiovascular events. These warnings underscore the importance of ongoing medical supervision while taking Rinvoq. The patient assistance program does not change the need for regular monitoring and follow-up appointments with your prescriber.
Alternative Savings Paths
If the Rinvoq PAP is not available to you, several alternatives exist. 340B pharmacies at qualifying hospitals and health centers may dispense Rinvoq at a reduced cost. Prescription discount cards offer modest savings on specialty drugs at retail pharmacies. State Pharmaceutical Assistance Programs can supplement Medicare Part D coverage for eligible residents.
For patients with commercial insurance facing high deductibles or coinsurance, the manufacturer savings card is the most impactful option. For uninsured patients, the PAP is typically the best path. Compare all available options and consult our healthcare costs guide for a strategic approach to managing prescription costs across your full medication list.
Frequently Asked Questions
Can I use Rinvoq Patient Assistance if I have Medicare?
Medicare Part D enrollees are generally ineligible for the Rinvoq Patient Assistance program. If you have Medicare but lack Part D or Medicare Advantage drug coverage, contact myAbbVie Assist at 1-800-222-6885 to discuss your eligibility. Medicare patients should also explore Extra Help Medicare and nonprofit copay foundations.
How long does approval take?
Most applications are processed within 2 to 4 weeks. Expedited processing may be available for urgent clinical needs. Your prescriber can call Rinvoq Complete to request faster review.
What if my insurance denies coverage for Rinvoq?
If your insurance denies Rinvoq coverage, AbbVie’s Rinvoq Complete team can help with the appeals process, including drafting letters of medical necessity and managing prior authorization requests. If the denial is upheld and you become effectively uninsured for Rinvoq, you may then qualify for the PAP.
Is there a generic version of Rinvoq?
As of 2026, there is no generic version of upadacitinib available in the United States. Rinvoq is protected by patents that extend its market exclusivity. When generic versions eventually enter the market, the cost is expected to drop substantially.
Can I receive Rinvoq at my local pharmacy through the PAP?
Rinvoq dispensed through the PAP is typically shipped directly to your home or your prescriber’s office by a specialty pharmacy. It is not dispensed at retail pharmacies through the assistance program. For retail pharmacy options, the savings card program for commercially insured patients works at participating pharmacies nationwide.
Start Your Application
Inflammatory conditions require consistent treatment to prevent flares and long-term damage. The Rinvoq Patient Assistance Program ensures that the cost of this important medication does not stand in the way of effective care. Contact your prescriber to begin the enrollment process, or call 1-800-222-6885 for direct support from the Rinvoq Complete team. Explore our healthcare costs guide for additional strategies to manage your overall healthcare spending.